These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 28490045)
1. Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions With IGFBP5 and THBS1. Haimes JD; Stewart CJR; Kudlow BA; Culver BP; Meng B; Koay E; Whitehouse A; Cope N; Lee JC; Ng T; McCluggage WG; Lee CH Am J Surg Pathol; 2017 Jun; 41(6):773-780. PubMed ID: 28490045 [TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement. Antonescu CR; Suurmeijer AJ; Zhang L; Sung YS; Jungbluth AA; Travis WD; Al-Ahmadie H; Fletcher CD; Alaggio R Am J Surg Pathol; 2015 Jul; 39(7):957-67. PubMed ID: 25723109 [TBL] [Abstract][Full Text] [Related]
3. Pregnancy-associated Inflammatory Myofibroblastic Tumors of the Uterus Are Clinically Distinct and Highly Enriched for TIMP3-ALK and THBS1-ALK Fusions. Devereaux KA; Fitzpatrick MB; Hartinger S; Jones C; Kunder CA; Longacre TA Am J Surg Pathol; 2020 Jul; 44(7):970-981. PubMed ID: 32271187 [TBL] [Abstract][Full Text] [Related]
4. ALK Is a Specific Diagnostic Marker for Inflammatory Myofibroblastic Tumor of the Uterus. Mohammad N; Haimes JD; Mishkin S; Kudlow BA; Leong MY; Chew SH; Koay E; Whitehouse A; Cope N; Ali RH; Köbel M; Stewart CJR; McCluggage WG; Lee CH Am J Surg Pathol; 2018 Oct; 42(10):1353-1359. PubMed ID: 30015720 [TBL] [Abstract][Full Text] [Related]
5. Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-RET fusion. Cheek EH; Fadra N; Jackson RA; Davila JI; Sukov WR; Uckerman MT; Clayton A; Keeney GL; Halling KC; Torres-Mora J; Schoolmeester JK Hum Pathol; 2020 Mar; 97():29-39. PubMed ID: 31917155 [TBL] [Abstract][Full Text] [Related]
6. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases. Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797 [TBL] [Abstract][Full Text] [Related]
7. Assessment of ALK Fusions in Uncommon Inflammatory Myofibroblastic Tumors With ALK IHC Positivity but FISH-Equivocal Findings by Targeted RNA Sequencing. Yao Q; Bai Q; Zhang X; Ji G; Chang H; Cai X; Yu L; Wang J; Zhu X; Zhou X Arch Pathol Lab Med; 2022 Oct; 146(10):1234-1242. PubMed ID: 35041745 [TBL] [Abstract][Full Text] [Related]
8. STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion. Subbiah V; McMahon C; Patel S; Zinner R; Silva EG; Elvin JA; Subbiah IM; Ohaji C; Ganeshan DM; Anand D; Levenback CF; Berry J; Brennan T; Chmielecki J; Chalmers ZR; Mayfield J; Miller VA; Stephens PJ; Ross JS; Ali SM J Hematol Oncol; 2015 Jun; 8():66. PubMed ID: 26062823 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts. Qiu X; Montgomery E; Sun B Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254 [TBL] [Abstract][Full Text] [Related]
10. Uterine inflammatory myofibroblastic tumor: First report of a ROS1 fusion. Bennett JA; Wang P; Wanjari P; Diaz L; Oliva E Genes Chromosomes Cancer; 2021 Dec; 60(12):822-826. PubMed ID: 34322931 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification. Takeuchi K; Soda M; Togashi Y; Sugawara E; Hatano S; Asaka R; Okumura S; Nakagawa K; Mano H; Ishikawa Y Clin Cancer Res; 2011 May; 17(10):3341-8. PubMed ID: 21430068 [TBL] [Abstract][Full Text] [Related]
12. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report. Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760 [TBL] [Abstract][Full Text] [Related]
13. Uterine Inflammatory Myofibroblastic Tumor Showing an Atypical ALK Signal Pattern by FISH and DES-ALK Fusion by RNA Sequencing: A Case Report. Zarei S; Abdul-Karim FW; Chase DM; Astbury C; Policarpio-Nicolas MLC Int J Gynecol Pathol; 2020 Mar; 39(2):152-156. PubMed ID: 30741845 [TBL] [Abstract][Full Text] [Related]
15. Histopathologic and Molecular Characterization of Uterine Leiomyoma-like Inflammatory Myofibroblastic Tumor: Comparison to Molecular Subtypes of Uterine Leiomyoma. Kuisma H; Jokinen V; Pasanen A; Heikinheimo O; Karhu A; Välimäki N; Aaltonen L; Bützow R Am J Surg Pathol; 2022 Aug; 46(8):1126-1136. PubMed ID: 35426837 [TBL] [Abstract][Full Text] [Related]
16. ALK Immunoexpression is Specific for Inflammatory Myofibroblastic Tumor Among Vulvovaginal Mesenchymal Neoplasms. Bowman CJ; Medeiros F; Fadare O; Sangoi AR; Horvai AE; Devine WP; McCluggage WG; Rabban JT Int J Gynecol Pathol; 2023 Jan; 42(1):1-10. PubMed ID: 35180768 [TBL] [Abstract][Full Text] [Related]
17. FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor. Ouchi K; Miyachi M; Tsuma Y; Tsuchiya K; Iehara T; Konishi E; Yanagisawa A; Hosoi H Pediatr Blood Cancer; 2015 May; 62(5):909-11. PubMed ID: 25682942 [TBL] [Abstract][Full Text] [Related]
18. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297 [TBL] [Abstract][Full Text] [Related]
19. Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel ATIC-ALK fusion mutation: a case report. Tateishi Y; Okudela K; Kawai S; Suzuki T; Umeda S; Matsumura M; Kioi M; Ohashi K Diagn Pathol; 2016 Nov; 11(1):132. PubMed ID: 27846861 [TBL] [Abstract][Full Text] [Related]
20. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]